Microbial Identification Market – By Product and Services (Instrument [PCR, Mass Spectrometer], Consumable, Software, Service), Method (Phenotypic, Genotypic), Application (Clinical Diagnostics, Pharmaceuticals), End-use – Global Forecast (2024 – 2032)

Microbial Identification Market Size

Microbial Identification Market size was valued at around USD 4.2 billion in 2023 and is estimated to grow at 8.8% CAGR from 2024 to 2032. Microbial identification is the process of determining the specific type or species of microorganisms present in a given sample. This involves identifying bacteria, viruses, fungi, parasites, or other microscopic organisms based on their unique characteristics such as morphological features, biochemical properties, genetic composition, or antigenic profiles.
 

The goal of microbial identification is to accurately classify microorganisms to understand their role in various contexts including disease diagnosis, environmental monitoring, food safety, pharmaceutical development, and biotechnology applications. The increasing prevalence of infectious diseases such as bacterial infections, viral infections, parasitic infections, etc. in microbial identification is significant driving factor for the market.
 

For instance, in 2022 World Health Organization (WHO) estimated that 254 million people were living with chronic hepatitis B infection, with 1.2 million new infections. During the year, hepatitis B caused an estimated 1.1 million deaths, due to complications such as cirrhosis and hepatocellular carcinoma (primary liver cancer). Thus, these underscore the critical need for advanced microbial identification solutions to effectively diagnose, treat, and prevent such infections.
 

Furthermore, rising technological advancements, growing awareness and screening programs, and increasing awareness about food safety, are the contributing factors stimulating the growth of the market.
 

Microbial Identification Market Trends

The ongoing progression of technological advancements has instigated a significant transformation in the market fundamentally reshaping the way microorganisms are detected and characterized. These advancements have provided researchers and healthcare professionals with a wide range of innovative tools and methods, facilitating more precise identification and comprehensive characterization of microorganism.
 

• Advances in molecular biology techniques such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and DNA microarray, which estimated to reach 7.8 billion by 2032 technology, enable rapid and precise identification of microorganisms based on their genetic profiles.
   
• The development of bioinformatics tools and databases represents a critical advancement in the field of microbial identification. These tools play a vital role in handling the vast amounts of complex data generated by sequencing and mass spectrometry techniques enabling researchers to interpret and analyze microbial genomes and proteomes with unprecedented accuracy and efficiency.
   
• Additionally, integration of automation and robotics into microbial identification systems streamlines workflow processes, reduces human error, and increases throughput making microbial identification more efficient and scalable, thereby escalating the growth of the market.
   

Microbial Identification Market Analysis

Based on product and services, the market is divided into instruments, consumables, software, and services. The instruments segment is bifurcated into mass spectrometers, PCR systems, microarrays, and other instruments. Further, the consumables segment is divided into reagents & kits and plates & media. The consumables segment is estimated to account for 3.5 billion by 2032.
 

• High-quality consumables such as culture media, reagents, and assay kits are designed and manufactured with stringent quality control measures, ensuring accurate and precise results in microbial identification assays.
   
• Standardized consumables provide consistency in experimental conditions minimizing variability between tests and facilitating reproducibility of results across different laboratories and experiments.
   
• Additionally, consumables are designed to be compatible with a wide range of instrumentation and platforms used in microbial identification providing researchers with flexibility in experimental setup and facilitating seamless integration into existing laboratory workflows. Thus, stimulating the growth of the segment.

Based on method, the microbial identification market is bifurcated into phenotypic methods, genotypic methods, and proteotypic methods. The genotypic methods segment accounted for USD 960.9 million in 2023.
 

• Genotypic methods target specific genetic markers such as DNA sequences or genetic mutations allowing for precise identification of microorganisms at the species or strain level.
   
• These methods can be applied to a wide range of microorganisms including bacteria, viruses, fungi, and parasites, making them versatile tools for microbial identification across diverse sample types and environments.
   
• Further, many genotypic methods offer rapid turnaround times allowing for quick and timely identification of microbial pathogens in clinical, environmental, or food samples. This accelerated diagnostic capability is particularly valuable for infectious disease management and outbreak detection. Thus, such aforementioned factors are expected to augment the segmental growth.
   

Based on application, the microbial identification market is segmented into clinical diagnostics, pharmaceuticals, cosmetic and personal care product testing, food and beverage testing, environmental application, and other applications. The clinical diagnostics segment is estimated to account for USD 2 billion by 2032.
 

• Clinical diagnostics employ a variety of methods such as culture-based techniques, molecular assays, and biochemical tests to accurately identify microbial pathogens causing infections in patients.
   
• Rapid diagnostic tests (RDTs) and point-of-care (POC) assays provide quick results  allowing healthcare professionals to promptly initiate appropriate treatment and improve patient outcomes.
   
• Further, by identifying the specific microbial pathogen causing an infection, clinical diagnostics enable healthcare providers to tailor treatment regimens to target the identified pathogen leading to more effective therapy and reduced antibiotics misuse.
   
• Thus, the aforementioned factors are anticipated to boost segmental growth.
   

Based on end-use, the microbial identification market is classified into pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, food testing laboratories, and other end-users. The hospitals and diagnostic laboratories segment accounted for USD 1.3 billion in 2023.
 

• Hospitals and diagnostic laboratories have direct access to patient samples, allowing for the timely collection and processing of specimens for microbial identification and diagnosis.
   
• Healthcare professionals including physicians, microbiologists, and medical technologists, possess specialized clinical expertise in interpreting microbial identification results and correlating them with patient’s clinical presentations.
   
• Moreover, hospitals and diagnostic laboratories are equipped with state-of-the-art instrumentation and technology for microbial identification including automated culture systems, molecular diagnostic platforms, and mass spectrometry-based systems. Thus, all these aforementioned factors are expected to drive segmental growth.

The U.S. microbial identification market is anticipated to grow at CAGR of 8.5% during the analysis timeframe.
 

• The country leads in technological innovation with access to cutting-edge tools and methodologies for microbial identification. Advances in genomics, proteomics, mass spectrometry, and bioinformatics drive progress in the field.
   
• There is a notable rise in the occurrence of infectious diseases such as bacterial, viral, and parasitic infections. For instance, the Centers for Disease Control and Prevention (CDCP) reports that in 2019, over 2.8 million infections in the U.S. are resistant to antimicrobial treatment, leading to over 35,000 deaths.
   

The UK is anticipated to witness robust growth in the global microbial identification market.
 

• The UK has a highly skilled workforce of healthcare professionals, microbiologists, and medical laboratory scientists who specialize in microbial identification. Their expertise ensures accurate interpretation of microbial identification results and informs clinical decision-making.
   

China microbial identification market is anticipated to witness lucrative growth between 2024 – 2032.
 

• China has made significant investments in biotechnology and genomics research, leading to the development of advanced sequencing technologies, bioinformatics tools, and high-throughput screening platforms for microbial identification.
   
• China's diverse ecosystems and vast geography support a rich microbial diversity, aiding researchers in comprehensively studying and identifying a wide range of organisms.
   

South Korea microbial identification market is expected to grow significantly over the years.
 

• South Korea is known for its technological innovation and expertise in biotechnology. South Korean researchers have developed advanced molecular biology techniques, high-throughput sequencing platforms, and bioinformatics tools for microbial identification.
   

Microbial Identification Market Share

The microbial identification industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.
 

Microbial Identification Market Companies

Some of the eminent market participants operating in the microbial identification industry include:

• Avantor, Inc.                                       
• bioMérieux SA                            
• Becton, Dickinson and Company             
• Bruker Corporation                                         
• Beckman Coulter, Inc.                                              
• Biolog, Inc.                                          
• Charles River Laboratories International, Inc.      
• Eurofins Scientific                                          
• Merck KGaA                                         
• Qiagen N.V.                                        
• Shimadzu Corporation                                              
• Thermo Fisher Scientific Inc.                  
• Wickham Micro Limited       
   

Microbial Identification Industry News:

• In April 2023, Bruker Corporation introduced new mycobacteria and fungi in-vitro diagnostic (IVD) solutions for MALDI Biotyper, along with a novel liquid array gastrointestinal syndromic panel. These advancements expanded the company's product portfolio, offering enhanced diagnostic capabilities for mycobacterial and fungal infections, as well as gastrointestinal syndromes.
   
• In May 2023, Charles River Laboratories International, Inc. launched Accugenix next generation sequencing for bacterial identification and fungal identification. The technology simultaneously sequenced millions of individual DNA fragments from a sample. This innovative solution benefited the company by enhancing its microbial identification capabilities, offering more comprehensive and accurate results to its clients, thereby strengthening its position as a leader in microbial testing services.
   

The microbial identification market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product and Services

• Instruments
  • Mass spectrometers
  • PCR systems
  • Microarrays
  • Other instruments
• Consumables
  • Reagents and kits   
  • Plates and media              
• Software
• Services                          

Market, By Method

• Phenotypic methods
• Genotypic methods
• Proteotypic methods

Market, By Application

• Clinical diagnostics   
• Pharmaceuticals
• Cosmetic and personal care product testing
• Food and beverage testing
• Environmental application
• Other applications

Market, By End-use

• Pharmaceutical and biotechnology companies                       
• Hospitals and diagnostic laboratories                          
• Food testing laboratories    
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa